Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia Roberta d'Emmanuele di Villa Bianca1

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 39, 2013, Pages 15812-15817

  D'Emmanuele di Villa Bianca, R ^a   Mitidieri, Emma ^a   Di Minno, Matteo N D ^a   Kirkby, Nicholas S ^b,c   Warner, Timothy D ^c   Di Minno, Giovanni ^a   Cirino, Giuseppe ^a   Sorrentino, Raffaella ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Aminooxyacetic acid; Cardiovascular events; DL propargylglycine; H2S gaseous transmitter; Urinary 11 dehydro TXB2

Indexed keywords

ARACHIDONIC ACID; COLLAGEN; CYSTATHIONINE BETA SYNTHASE; CYSTEINE; HYDROGEN SULFIDE; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; THROMBOXANE A2; THROMBOXANE B2;

ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HYPERHOMOCYSTEINEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE AGGREGATION; WESTERN BLOTTING;

EID: 84884641941     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1309049110     Document Type: Article

References (37)

1. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274(13):1049-1057.
2. Beard RS, Jr., Bearden SE (2011) Vascular complications of cystathionine ?-synthase deficiency: Future directions for homocysteine-to-hydrogen sulfide research. Am J Physiol Heart Circ Physiol 300(1):H13-H26.
3. Austin RC, Lentz SR, Werstuck GH (2004) Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 11(Suppl 1):S56-S64.
4. Towfighi A, Saver JL, Engelhardt R, Ovbiagele B (2008) Factors associated with the steep increase in late-midlife stroke occurrence among US men. J Stroke Cerebrovasc Dis 17(4):165-168.
5. Kawamoto R, Kajiwara T, Oka Y, Takagi Y (2002) An association between plasma homocysteine concentrations and ischemic stroke in elderly Japanese. J Atheroscler Thromb 9(2):121-125.
6. Lee R, Frenkel EP (2003) Hyperhomocysteinemia and thrombosis. Hematol Oncol Clin North Am 17(1):85-102.
7. Fay WP (2012) Homocysteine and thrombosis: Guilt by association? Blood 119 (13) 2977-2978.
8. Leoncini G, Pascale R, Signorello MG (2003) Effects of homocysteine on l-arginine transport and nitric oxide formation in human platelets. Eur J Clin Invest 33(8):713-719.
9. Undas A, Brozek J, Szczeklik A (2005) Homocysteine and thrombosis: From basic science to clinical evidence. Thromb Haemost 94(5):907-915.
10. Selhub J (1999) Homocysteine metabolism. Annu Rev Nutr 19:217-246.
11. Davis SR, et al. (2004) Tracer-derived total and folate-dependent homocysteine remethylation and synthesis rates in humans indicate that serine is the main one-carbon donor. Am J Physiol Endocrinol Metab 286(2):E272-E279.
12. Loscalzo J (2006) Homocysteine trials-Clear outcomes for complex reasons. N Engl J Med 354(15):1629-1632.
13. Kimura H (2011) Hydrogen sulfide: Its production, release and functions. Amino Acids 41(1):113-121.
14. Whitfield NL, Kreimier EL, Verdial FC, Skovgaard N, Olson KR (2008) Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am J Physiol Regul Integr Comp Physiol 294(6):R1930-R1937.
15. Jha S, Calvert JW, Duranski MR, Ramachandran A, Lefer DJ (2008) Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: Role of antioxidant and antiapoptotic signaling. Am J Physiol Heart Circ Physiol 295(2):H801-H806.
16. Tang G, Wu L, Wang R (2010) Interaction of hydrogen sulfide with ion channels. Clin Exp Pharmacol Physiol 37(7):753-763.
17. d'Emmanuele di Villa Bianca R, et al. (2011) Hydrogen sulfide-induced dual vascular effect involves arachidonic acid cascade in rat mesenteric arterial bed. J Pharmacol Exp Ther 337(1):59-64.
18. Bucci M, et al. (2010) Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. Arterioscler Thromb Vasc Biol 30(10):1998-2004.
19. Predmore BL, Lefer DJ, Gojon G (2012) Hydrogen sulfide in biochemistry and medicine. Antioxid Redox Signal 17(1):119-140.
20. Ramakrishnan S, Sulochana KN, Lakshmi S, Selvi R, Angayarkanni N (2006) Biochemistry of homocysteine in health and diseases. Indian J Biochem Biophys 43(5): 275-283.
21. de Franchis R, et al. (1996) Elevated total plasma homocysteine and 677C->T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease. Am J Hum Genet 59(1):262-264.
22. D'Angelo A, et al. (2000) The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events. Thromb Haemost 83(4):563-570.
23. Zagli G, et al. (2007) Hydrogen sulfide inhibits human platelet aggregation. Eur J Pharmacol 559(1):65-68.
24. Di Minno MN, et al. (2011) Genotype-independent in vivo oxidative stress following a methionine loading test: Maximal platelet activation in subjects with early-onset thrombosis. Thromb Res 128(4):e43-e48.
25. Eftychiou C, et al. (2012) Homocysteine levels and MTHFR polymorphisms in young patients with acute myocardial infarction: A case control study. Hellenic J Cardiol 53(3):189-194.
26. Aksoy M, et al. (2006) Hyperhomocysteinemia in patients with arterial occlusive disease. Surg Today 36(4):327-331.
27. Weiss N, Keller C, Hoffmann U, Loscalzo J (2002) Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia. Vasc Med 7(3):227-239.
28. Di Minno G, et al. (1993) Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism. J Clin Invest 92(3):1400-1406.
29. Coppola A, et al. (2000) Homocysteine, coagulation, platelet function, and thrombosis. Semin Thromb Hemost 26(3):243-254.
30. Davi G, et al. (2001) Oxidative stress and platelet activation in homozygous homocystinuria. Circulation 104(10):1124-1128.
31. d'Emmanuele di Villa Bianca R, et al. (2010) Hydrogen sulphide induces mouse paw oedema through activation of phospholipase A2. Br J Pharmacol 161(8):1835-1842.
32. Lentz SR (2005) Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost 3(8):1646-1654.
33. Vargas JR, Radomski M, Moncada S (1982) The use of prostacyclin in the separation from plasma and washing of human platelets. Prostaglandins 23(6):929-945.
34. Born GV (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:927-929.
35. Kirkby N, Cabirol S, Mazille M, Mitchell J, Warner T (2011) Development of a homogenous time-resolved fluorescence-based immunoassay for the evaluation of platelet thromboxane release. pA2online 9(3):075P.
36. Sun B, Tandon NN, Yamamoto N, Yoshitake M, Kambayashi JI (2001) Luminometric assay of platelet activation in 96-well microplate. Biotechniques 31(5):1174-1181, 1176, 1178 passim.
37. Fusco F, et al (2012) Sildenafil effect on the human bladder involves the L-cysteine/ hydrogen sulfide pathway: A novel mechanism of action of phosphodiesterase type inhibitors. Eur Urol 62(6):1174-1180.